4
Changes in Ownership
Context Therapeutics Inc. Filed Acc 0001628280-26-045778
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smith Karen L. Director | 2026-06-24 | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | D | ||
Loading xslF345X06/wk-form4_1782505215.xml…